If price hikes were an Olympic event, pharma would take gold, silver, and bronze.

Welcome to the Week in Review.

1. Putting The Brakes On Patent Abuse

2. 100 Years Later, A $100 Biosimilar

3. Rep. Peters’ Flip Flop: Unforgivable

One more thing: This week, members of Congress highlighted pharma’s July price hikes and the need for Medicare to negotiate lower prices. Check it out here.